『S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action』のカバーアート

S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action

S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 Visit http://morningcommutepodcast.com/SGLT2inhibitors6 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, Dr. James Januzzi and Dr. Silvio Inzucchi discuss the surge in collaboration between primary care physicians, endocrinologists, and cardiologists and the groundswell of cardiometabolic clinics. They attribute this to cardiologists moving beyond the so-called glucocentric view and focusing on how diabetes therapies might help reduce cardiovascular risk as well. Drs. Januzzi and Inzucchi will also discuss the recent guidelines that now incorporate sodium-glucose cotransporter 2 (SGLT-2) inhibitors into clinical pathways.

S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Actionに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。